Participants 149 199 6
recurrent or refractory non small-cell lung cancer
Participants 932 1054 5
All patients had histologically confirmed nonsquamous NSCLC that had progressed during or after one platinum-based regimen
Participants 1064 1091 7
One hundred twenty patients
